Presentation at Exelixis Pharma. “Nitrosamine Challenges in Drug Development: Are You Prepared?”

Download video

Presentation at Exelixis Pharma. “Nitrosamine Challenges in Drug Development: Are You Prepared?”

9.3K views

Emery Pharma

9 hours ago

Presentation at Exelixis Pharma. “Nitrosamine Challenges in Drug Development: Are You Prepared?”

12:13

From Molecule to Formulation A Systematic Approach to Assess Biologics Developability - Poster

by Catalent Pharma Solutions

2:02:35

PBRER Section 2 to 4

by PharmaIdiots

13:31

Role of Excipients in Solid Dosage Forms

by Pharma Learning In Depth

17:38

ICH Q1 Latest Part 2

by Pharma World K

9:42

How to Handle Nitrosamines in Exhibit Batch Stability

by Pharma Learning In Depth

$Q1 Q2 Q3 De-formulation \& Equivalence$

5:55

Q1 Q2 Q3 De-formulation \& Equivalence

by Pharma Learning In Depth

8:53

Assay and Related Substances RS

by Pharma Learning In Depth

8:10

When is Nitrosamine Testing Required in Formulation

by Pharma Learning In Depth

9:31

Granulation Techniques in the Pharmaceutical Industry

by Pharma Learning In Depth

15:43

FDA Form 483 Overview

by Pharma Learning In Depth

9:16

Introduction to Cell Transfection: Part 2

by Applied Biological Materials - abm

$🩸 Bacteremia and Clinical Resistance Objective 2 | Spectrum Glycopeptide, Lipopeptides \& β-Lactams 🔬$

25:43

🩸 Bacteremia and Clinical Resistance Objective 2 | Spectrum Glycopeptide, Lipopeptides \& β-Lactams 🔬

by Alireza FakhriRavari, PharmD, BCPS, BCIDP, AAHIVP

1:14:28

Implementing AI systems in regulated pharmaceutical environments

by BioPhorum

$CATALYSTCue Vol. 2, Issue 2 | Precision, Integration \& Innovation for Tomorrow’s Labs$

0:49

CATALYSTCue Vol. 2, Issue 2 | Precision, Integration \& Innovation for Tomorrow’s Labs

by Inkarp Instruments Private Limited

13:08

Critical Process Parameters CPPs in Tablet Coating

by Pharma Learning In Depth

3:38

Blend and Content Uniformity

by Pharma Learning In Depth

11:22

Artificial intelligence in pharmaceutical industry impact and benefits. You must know. 🤖😇

by Pharmexcel

10:32

AI Limits for Nitrosamines

by Pharma Learning In Depth

$FDA Advancing Generic Drugs 2025: Glatiramer Acetate Injectable \& Pentosan Polysulfate Capsules$

30:27

FDA Advancing Generic Drugs 2025: Glatiramer Acetate Injectable \& Pentosan Polysulfate Capsules

by The FDA Learning Cache

51:46

Multicompartmental Pharmacokinetic Modeling with Dr. Scott R. Penzak

by NIH Clinical Center

Best on Vidoe

Presentation at Exelixis Pharma. “Nitrosamine Challenges in Drug Development: Are You Prepared?”